Angi Inc (ANGI) concluded trading on Wednesday at a closing price of $15.15, with 4.68 million shares of worth about $70.85 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -35.53% during that period and on May 07, 2025 the price saw a gain of about 34.67%. Currently the company’s common shares owned by public are about 49.54M shares, out of which, 43.36M shares are available for trading.
Stock saw a price change of 32.20% in past 5 days and over the past one month there was a price change of 24.59%. Year-to-date (YTD), ANGI shares are showing a performance of -8.73% which decreased to -40.35% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $10.88 but also hit the highest price of $29.15 during that period. The average intraday trading volume for Angi Inc shares is 831.05K. The stock is currently trading 24.33% above its 20-day simple moving average (SMA20), while that difference is up 6.85% for SMA50 and it goes to -23.61% lower than SMA200.
Angi Inc (NASDAQ: ANGI) currently have 49.54M outstanding shares and institutions hold larger chunk of about 10.07% of that.
The stock has a current market capitalization of $539.85M and its 3Y-monthly beta is at 1.69. PE ratio of stock for trailing 12 months is 14.52, while it has posted earnings per share of $1.04 in the same period. Its PEG reads 0.59 and has Quick Ratio of 2.15 while making debt-to-equity ratio of 0.47. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ANGI, volatility over the week remained 6.12% while standing at 6.25% over the month.
Stock’s fiscal year EPS is expected to drop by -18.33% while it is estimated to increase by 47.77% in next year. EPS is likely to grow at an annualized rate of 24.78% for next 5-years, compared to annual growth of 1.11% made by the stock over the past 5-years.
Coverage by Goldman stated Angi Inc (ANGI) stock as a Neutral in their note to investors on November 13, 2024, suggesting a price target of $2.50 for the stock. On November 13, 2024, Citigroup Downgrade their recommendations, while on July 09, 2024, JMP Securities Initiated their ratings for the stock with a price target of $3.25. Stock get a Neutral rating from UBS on February 15, 2023.
